Sanofi Consumer rallies 15% on strong profit jump of 50% in Q4; revenue up 47%
News by Aliceblue News Desk
26 Feb 2026

Introduction
Leading consumer healthcare firm reported strong Q4 and full-year growth, with revenue up 47% quarterly and 21% annually, and profit after tax increasing 50% and 33% respectively.
Also Read: IOL Chemicals & Pharmaceuticals receives EDQM CEP for Clopidogrel Besilate API; stock moves up 4%
Share price movement of Sanofi Consumer
On February 26, 2026, Sanofi Consumer Healthcare India Ltd opened at ₹4,200.10, up 4.87% from its previous close of ₹4,005.75. The stock reached a high of ₹4,647.70 (15.25%) and a low of ₹4,200.10. By 12:03 PM, it traded at ₹4,616.75, a 15.25% increase, with a market cap of ₹10,632.66 crore.
Sanofi Consumer Q4 FY25 Results
Sanofi Consumer Healthcare India Limited reported Q4 FY25 revenue of ₹2,510 million, up 47% year-on-year. Domestic sales grew 23%, while export sales rose 9.3 times due to a low base effect.
Profit after tax for Q4 FY25 reached ₹665 million, reflecting a 50% increase year-on-year. Growth was supported by the relaunch of recalled products and improved operational efficiency across segments.
For the full year FY25, Sanofi Consumer Healthcare India Limited recorded revenue of ₹8,784 million, representing a 21% increase over FY24. Domestic sales grew 7%, while exports surged 158%.
Full-year profit after tax stood at ₹2,401 million, up 33% compared to the previous year. The company declared a dividend of ₹75 per share for FY25.
Stock performance of Sanofi Consumer for period of 1 week, 6 months, and 1 year
Sanofi Consumer Healthcare India Ltd declined 0.93% over the past week and fell 22.7% in the past six months. The stock dropped 12.4% over the past year.
Shareholding pattern of Sanofi Consumer
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
| Promoter | 71.30% | 71.30% | 71.30% |
| FII | 2.80% | 2.90% | 3.20% |
| DII | 17.30% | 17.20% | 16.90% |
| Public | 8.60% | 8.60% | 8.60% |
About Sanofi Consumer
Sanofi Consumer Healthcare India Limited (NSE: SANOFICONR) operates independently in India’s consumer healthcare sector, offering products in allergy, digestive wellness, pain care, and multivitamins under key brands.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Sanofi Consumer Healthcare India Limited share price rising today?
A: Sanofi Consumer Healthcare India Limited share price rose after reporting Q4 FY25 revenue of ₹2,510 million and profit after tax of ₹665 million.
Q: What is Sanofi Consumer Healthcare India Limited’s main business focus?
A: Sanofi Consumer Healthcare India Limited focuses on consumer healthcare products in allergy, digestive wellness, pain care, and multivitamins across India.
Q: What are the 52-week high and low of Sanofi Consumer Healthcare India Limited stock?
A: Sanofi Consumer Healthcare India Limited 52-week high is ₹5,954.00 and 52-week low is ₹3,967.00.

News Author
Aliceblue News Desk















